Inflammatory Markers and Infertility: A New Link in Diagnostic Testing
Recent research published in the International Journal of Gynecology & Obstetrics reveals a significant association between novel high-density lipoprotein-related inflammation indices and female infertility. Analyzing data from the National Health and Nutrition Examination Survey (NHANES), the cross-sectional study found that elevated Monocyte-to-HDL (MHR) and Lymphocyte-to-HDL (LHR) ratios are positively correlated with increased odds of infertility. After adjusting for confounders, individuals in the highest quartiles for MHR and LHR had a 70% and 54% higher chance of infertility prevalence, respectively. This study highlights the potential of these convenient, cost-effective hematology and clinical chemistry biomarkers for evaluating inflammatory contributions to reproductive health, offering a new avenue for diagnostic algorithms beyond traditional endocrine assays.
Study Significance: For professionals in laboratory medicine, this research underscores the expanding role of routine hematology testing and immunoassays in complex diagnostic puzzles. The findings suggest that integrating MHR and LHR into metabolic and inflammatory panels could refine risk stratification for conditions like infertility, moving beyond standard hormone testing. This shift emphasizes the need for robust clinical correlation and post-analytical interpretation to translate novel biomarker ratios into actionable clinical insights, potentially influencing future reference ranges and quality assurance protocols in reproductive health diagnostics.
Source →Stay curious. Stay informed — with Science Briefing.
This is a one time Briefing, Upgrade to continue.
